Valuation: ViaDerma, Inc.

Market Cap 6.31M 5.47M 5.13M 4.68M 8.78M 602M 8.93M 60.22M 23.55M 302M 23.67M 23.16M 1.01B P/E 2015
10.7x
P/E 2016 -3.3x
Enterprise Value 6.6M 5.73M 5.37M 4.9M 9.2M 630M 9.35M 63.05M 24.66M 316M 24.79M 24.25M 1.05B EV / Sales 2015
1.5x
EV / Sales 2016 3.63x
Free-Float
99%
Yield 2015 *
-
Yield 2016 -
1 day+150.00%
1 week+25.00%
Current month+400.00%
1 month+25.00%
3 months+25.00%
Current year+150.00%
1 week 0
Extreme 0.0002
0
1 month 0
Extreme 1.0E-6
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0.01
3 years 0
Extreme 1.0E-6
0.02
5 years 0
Extreme 1.0E-6
0.03
10 years 0
Extreme 1.0E-6
0.08
Manager TitleAgeSince
Chief Executive Officer - 2014-03-30
Director TitleAgeSince
Chairman - 2014-03-30
Change 5-day change 1-year change 3-year change Capi.($)
+150.00%+25.00%+400.00%-94.95% 247K
+1.17%+2.03%+4.91%+15.74% 48.72B
-1.59%+2.38%+472.89%+573.56% 43.99B
-0.85%+8.70%+23.57%+80.09% 40.82B
-0.08%+2.32%+29.91%+9.86% 39.79B
0.00%+6.15%+23.03%+48.00% 32.7B
-2.52%-0.99%+26.71%+118.05% 16.66B
-3.61%+0.83% - - 16.84B
+0.72%+0.60%+4.97%+21.70% 13.95B
-1.09%+7.88%+84.14%+31.15% 13.58B
Average +14.21%-1.66%+118.90%+89.24% 26.7B
Weighted average by Cap. -0.59%+3.66%+102.34%+135.59%

Financials

2015 2016
Net sales 192K 166K 156K 142K 267K 18.3M 272K 1.83M 716K 9.17M 720K 704K 30.58M 252K 219K 205K 187K 351K 24.05M 357K 2.41M 941K 12.05M 946K 925K 40.18M
Net income 27.12K 23.52K 22.08K 20.11K 37.78K 2.59M 38.41K 259K 101K 1.3M 102K 99.6K 4.33M -122K -106K -99.15K -90.31K -170K -11.62M -172K -1.16M -455K -5.83M -457K -447K -19.42M
Net Debt 288K 250K 235K 214K 402K 27.51M 408K 2.75M 1.08M 13.78M 1.08M 1.06M 45.97M 297K 257K 242K 220K 413K 28.32M 420K 2.83M 1.11M 14.19M 1.11M 1.09M 47.33M
Logo ViaDerma, Inc.
ViaDerma, Inc. is a pharmaceutical company. The Company is engaged in the manufacture and sale of pharmaceutical related products in the United States of America. The Company’s lead product is a topical antibiotic, which is focused on being sold under the brand name Vitastem. The Company also has products in development in the fields: anti-aging skin care, pain management, hair-loss, and toenail fungus. Its products are based on a patent-pending delivery system technology that allows for rapid mass transfer of the pharmaceutical active ingredient across the skin and into the body to provide immediate localized therapy. The Company utilizes a specific trade secret formulation system in the manufacture of all products. The Company’s products are sold to local medical practitioners and patients in clinics primarily in the Los Angeles, California area. The Company’s subsidiary is ViaDerma, II Inc.
Employees
75
Date Price Change Volume
26-08-13 US$0.000500 +150.00% 503,000
26-08-12 US$0.000200 -66.67% 3,200
26-08-11 US$0.000600 +20.00% 300,125
26-08-10 US$0.000500 +25.00% 344,441
26-08-07 US$0.000400 +100.00% 275,000
  1. Stock Market
  2. Stocks
  3. VDRM Stock